Centessa Pharmaceuticals plc
CNTA
$16.44
-$0.56-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.63% | 76.52% | -161.54% | 2.85% | -15.17% |
| Total Depreciation and Amortization | 4.15% | 141.11% | 9.76% | -65.25% | -1.67% |
| Total Amortization of Deferred Charges | -6.09% | 122.86% | -9.09% | -- | -- |
| Total Other Non-Cash Items | 31.28% | -84.24% | 384.15% | 0.33% | -8.36% |
| Change in Net Operating Assets | 148.00% | -252.67% | 109.21% | 304.73% | 35.89% |
| Cash from Operations | 60.78% | -33.75% | -100.10% | 47.29% | -8.83% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.09% | -989.55% | -44.44% | 181.14% | -430.86% |
| Cash from Investing | 82.03% | -989.55% | -44.40% | 181.08% | -430.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.34% | 48.19% | -97.85% | 128.50% | 929.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 191.73% | -201.58% | -63.61% | -- | -- |
| Cash from Financing | -47.99% | 4.15% | -98.80% | 133.57% | 903.65% |
| Foreign Exchange rate Adjustments | 92.55% | -150.03% | 259.24% | -1,486.67% | -154.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.09% | -2,255.48% | -104.41% | 2,823.90% | 193.29% |